|
GPN1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.72768999999739E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.196430E-03 |
| Normal-vs-Stage2 |
1.849990E-02 |
| Normal-vs-Stage3 |
7.844200E-03 |
| Normal-vs-Stage4 |
8.826200E-02 |
| Stage1-vs-Stage2 |
5.514400E-01 |
| Stage1-vs-Stage3 |
4.041000E-01 |
| Stage1-vs-Stage4 |
3.987600E-01 |
| Stage2-vs-Stage3 |
9.056800E-01 |
| Stage2-vs-Stage4 |
7.248600E-01 |
| Stage3-vs-Stage4 |
7.902200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.04750000000798E-05 |
| Normal-vs-AfricanAmerican |
4.414300E-04 |
| Normal-vs-Asian |
3.905800E-01 |
| Caucasian-vs-AfricanAmerican |
6.933200E-01 |
| Caucasian-vs-Asian |
8.481600E-01 |
| AfricanAmerican-vs-Asian |
9.481200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.081000E-03 |
| Normal-vs-Female |
1.99180000048926E-07 |
| Male-vs-Female |
2.598500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.586100E-02 |
| Normal-vs-Extreme_Weight |
1.476260E-02 |
| Normal-vs-Obese |
6.776800E-04 |
| Normal-vs-Extreme_Obese |
4.393000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.475000E-01 |
| Normal_Weight-vs-Obese |
1.220210E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.492800E-01 |
| Extreme_Weight-vs-Obese |
1.939190E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.830800E-01 |
| Obese-vs-Extreme_Obese |
5.639800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.543100E-03 |
| Normal-vs-Age(41-60Yrs) |
1.388830E-04 |
| Normal-vs-Age(61-80Yrs) |
6.842500E-04 |
| Normal-vs-Age(81-100Yrs) |
3.602600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.580300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.226100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.984100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.807000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.360400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.747400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.81909999999697E-05 |
| Normal-VS-Type2 PRCC |
1.602120E-02 |
| Normal-VS-KIRP CIMP |
5.229200E-04 |
| Normal-VS-Unclassified PRCC |
4.380100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.860800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.619050E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.867600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.619200E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.720200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.629780E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.941000E-01 |
| Normal-vs-N1 |
5.555100E-03 |
| Normal-vs-N2 |
1.221880E-02 |
| N0-vs-N1 |
1.859660E-02 |
| N0-vs-N2 |
2.694200E-01 |
| N1-vs-N2 |
6.485800E-01 |
|
|
